The ECMO-Free Trial

NAEnrolling by invitationINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions
Extracorporeal Membrane Oxygenation Complication
Interventions
OTHER

ECMO-free protocol

"All patients randomized to the ECMO-Free Protocol Group will receive a protocolized daily assessment of readiness for liberation from VV-ECMO, which will be initiated between 6:00 AM local time and 10:00 AM local time. If the patient is enrolled after 10:00 AM local time the ECMO-free protocol will begin the following calendar day.~The ECMO-Free Protocol is a 3-step process of assessing readiness for liberation from VV-ECMO: a safety screen (Phase 1: ECMO-Free Safety Screen), titration of the non-ECMO fraction of inspired oxygen (Phase 2: Non-ECMO respiratory support titration), and a trial of cessation of sweep gas flow (Phase 3: ECMO-Free Trial)."

OTHER

Usual Care

All patients randomized to the Usual Care Group will undergo assessments of readiness for liberation, weaning, and decannulation at the discretion of the treatment team.

Trial Locations (8)

37232

Vanderbilt University Medical Center, Nashville

55415

Hennepin County Medical Center, Minneapolis

75235

Texas Tech University Health Sciences Center, Dallas

75246

Baylor University Medical Center, Dallas

84112

University of Utah Health, Salt Lake City

92037

UC San Diego Health, San Diego

94305

Stanford University, Stanford

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER